These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 1740478)

  • 1. Urinary pyridinium cross-links as markers of bone resorption in tumor-associated hypercalcemia.
    Body JJ; Delmas PD
    J Clin Endocrinol Metab; 1992 Mar; 74(3):471-5. PubMed ID: 1740478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links.
    Uebelhart D; Schlemmer A; Johansen JS; Gineyts E; Christiansen C; Delmas PD
    J Clin Endocrinol Metab; 1991 Feb; 72(2):367-73. PubMed ID: 1991806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease.
    Garnero P; Gineyts E; Riou JP; Delmas PD
    J Clin Endocrinol Metab; 1994 Sep; 79(3):780-5. PubMed ID: 8077361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of clodronate in patients with multiple myeloma. Evaluation of specific markers of bone resorption].
    Slabý J; Spicka I; Hulejová H; Spacek P; Cieslar P; Klener P
    Cas Lek Cesk; 1997 Jan; 136(2):57-60. PubMed ID: 9147856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis.
    Delmas PD; Schlemmer A; Gineyts E; Riis B; Christiansen C
    J Bone Miner Res; 1991 Jun; 6(6):639-44. PubMed ID: 1887826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked diurnal variation in urinary excretion of pyridinium cross-links in premenopausal women.
    Schlemmer A; Hassager C; Jensen SB; Christiansen C
    J Clin Endocrinol Metab; 1992 Mar; 74(3):476-80. PubMed ID: 1740479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of urinary pyridinium crosslink excretion as a marker of bone resorption in the rat.
    Egger CD; Mühlbauer RC; Felix R; Delmas PD; Marks SC; Fleisch H
    J Bone Miner Res; 1994 Aug; 9(8):1211-9. PubMed ID: 7976504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related changes of urinary pyridinoline and deoxypyridinoline in Japanese subjects.
    Ohishi T; Takahashi M; Kawana K; Aoshima H; Hoshino H; Horiuchi K; Kushida K; Inoue T
    Clin Invest Med; 1993 Oct; 16(5):319-25. PubMed ID: 8261685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of alendronate on plasma calcium levels, urinary calcium excretion, and bone resorption markers in normal rats: comparison with elcatonin, synthetic eel calcitonin.
    Azuma Y; Chokki M; Ohta T; Kiyoki M
    Endocrinology; 1996 Jun; 137(6):2586-92. PubMed ID: 8641213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of markers of bone resorption in patients with breast cancer-induced osteolysis before and after bisphosphonate therapy.
    Body JJ; Dumon JC; Gineyts E; Delmas PD
    Br J Cancer; 1997; 75(3):408-12. PubMed ID: 9020487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease.
    Alvarez L; Guañabens N; Peris P; Monegal A; Bedini JL; Deulofeu R; Martinez de Osaba MJ; Muñoz-Gomez J; Rivera-Fillat F; Ballesta AM
    J Bone Miner Res; 1995 Mar; 10(3):458-65. PubMed ID: 7785468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Assay of urinary pyridinoline and deoxypyridinoline as potential markers of the rate of bone resorption: usefulness of urinary pyridinoline and deoxypyridinoline in patients with prostate cancer with bone metastases].
    Takeuchi S; Yoshida K
    Nihon Hinyokika Gakkai Zasshi; 1994 Oct; 85(10):1521-7. PubMed ID: 7990300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markers of bone turnover in hyperthyroidism and the effects of treatment.
    Garnero P; Vassy V; Bertholin A; Riou JP; Delmas PD
    J Clin Endocrinol Metab; 1994 Apr; 78(4):955-9. PubMed ID: 8157727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption.
    Robins SP; Woitge H; Hesley R; Ju J; Seyedin S; Seibel MJ
    J Bone Miner Res; 1994 Oct; 9(10):1643-9. PubMed ID: 7817812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study.
    Garnero P; Hausherr E; Chapuy MC; Marcelli C; Grandjean H; Muller C; Cormier C; Bréart G; Meunier PJ; Delmas PD
    J Bone Miner Res; 1996 Oct; 11(10):1531-8. PubMed ID: 8889854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different responses of free and peptide-bound cross-links to vitamin D and calcium supplementation in elderly women with vitamin D insufficiency.
    Kamel S; Brazier M; Rogez JC; Vincent O; Maamer M; Desmet G; Sebert JL
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3717-21. PubMed ID: 8855828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of urinary pyridinoline excretion with a specific enzyme-linked immunosorbent assay in normal adults and in metabolic bone diseases.
    Arbault P; Grimaux M; Pradet V; Preaudat C; Seguin P; Delmas PD
    Bone; 1995 Apr; 16(4):461-7. PubMed ID: 7605707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in urinary excretion of deoxypyridinoline in tail-suspended rats: effects of a bisphosphonate, YH529.
    Ohmori S; Kurokouchi K; Kanda K; Kawano S; Ito T; Inazu M; Kambe F; Seo H
    Environ Med; 1998 Oct; 42(1):11-3. PubMed ID: 12212616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of new bone resorption markers in a randomized comparison of pamidronate or clodronate for hypercalcemia of malignancy.
    Vinholes J; Guo CY; Purohit OP; Eastell R; Coleman RE
    J Clin Oncol; 1997 Jan; 15(1):131-8. PubMed ID: 8996134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary excretion of pyridinium cross-links in healthy women; the long-term effects of menopause and oestrogen/progesterone therapy.
    Schlemmer A; Hassager C; Delmas PD; Christiansen C
    Clin Endocrinol (Oxf); 1994 Jun; 40(6):777-82. PubMed ID: 8033369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.